ELAINE LA: Open Payments
NPI 1396055240 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,079 in 210 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,980 · 2025 $6,079
Food & beverage: $5,984Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $1,428 |
| Janssen Biotech, Inc. | 44 | $783 |
| Amgen Inc. | 31 | $690 |
| UCB, Inc. | 16 | $608 |
| Novartis Pharmaceuticals Corporation | 14 | $440 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $428 |
| Lilly USA, LLC | 16 | $400 |
| AstraZeneca Pharmaceuticals LP | 10 | $334 |
| Mallinckrodt Hospital Products Inc. | 7 | $280 |
| Radius Health, Inc. | 8 | $263 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Bimzelx, TALTZ, COSENTYX, SAPHNELO, ACTHAR.
Industry payments across CA — which companies pay providers there.
